ETFs Holding NVLS »    NVLS Historical Stock Prices »
NVLS News Video: Fri, May 17, 2019, 2:22 PM — Daily Dividend Report: FDS, KRC, COR, UNP, NVDA

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nivalis Therapeutics is a clinical stage pharmaceutical company engaged in the discovery, development and commercialization of product candidates for patients with cystic fibrosis (CF). Co.'s key product candidate, N91115, is a small molecule compound that addresses a defect in the cystic fibrosis transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR gene, the underlying cause of CF. Co. is conducting a clinical trial in CF patients who have two copies of the F508del mutation, a type of CFTR mutation. This trial is designed to assess the efficacy and safety of N91115 in a triple therapy with two other CFTR modulators, lumacaftor/ivacaftor. Self directed investors in Nivalis Therapeutics Inc will be interested in keeping up with all Nivalis Therapeutics Inc news they can find, both NVLS news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on NVLS. At RediNews, we simplify this task by presenting both NVLS news releases originating from Nivalis Therapeutics Inc itself, and NVLS news from a variety of media outlets. Visitors can browse this news online and through our NVLS RSS news feed.


NVLS News — Articles, Videos, & Press Releases

NVLS is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GI News

Consider RediNews RSS feeds to complement your web page financial content. Whether below a detailed quote page, a stock history chart, or featured on your home page, RediNews has an RSS feed to meet your needs. Integrate news by specific stock symbol, or an entire market sector. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): .

NVLS News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.